lilly glp 1 agonist Lilly's diabetes drug ahead of Novo Nordisk's in Q2 market share < Pharma < Article Orforglipron: Eli Lilly's New Oral
Description
Despite strong clinical evidence supporting the effectiveness of GLP-1 therapies for weight loss, coverage remains inconsistent and often restrictive
kidney problems including kidney failure
You must draw the medication into a syringe for each dose
However, ongoing research, such as the FLOW trial, which had been comparing GLP-1RAs to a placebo in patients with T2D and CKD, was recently halted prematurely due to their effectiveness
doi: 10.1161/HYPERTENSIONAHA.120.16876 46 UijlEMirabito ColafellaKMSunYRenLvan VeghelRGarreldsIMet al
In addition, tell your doctor that you take GLP-1 drugs if you are having surgery or a procedure that involves general anesthesia
